Related Experiment Video

Updated: Feb 4, 2026

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.7K

Prevention of Pediatric Pharmaceutical Poisonings

Nicole D White1, William Kibalama1

  • 1Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska.

American Journal of Lifestyle Medicine
|October 5, 2018
PubMed

Insights

Pediatric poisoning is a growing, preventable injury. Safe medication storage and disposal programs, like drug take-back initiatives, are crucial for protecting children from accidental ingestion.

Area of Science:

  • Public Health
  • Environmental Health
  • Pediatric Safety

Background:

  • Pediatric poisoning is a significant and increasing public health concern.
  • Increased adult prescription drug use elevates children's exposure risk.
  • Child-resistant packaging effectiveness depends on proper use.

Purpose of the Study:

  • To highlight the rising incidence of pediatric poisoning.
  • To emphasize the role of medication access in accidental poisonings.
  • To advocate for safe drug disposal practices.

Main Methods:

  • Review of current literature on pediatric poisoning trends.
  • Analysis of factors contributing to increased medication exposure in homes.
  • Examination of the impact of child-resistant packaging and drug take-back programs.

Main Results:

  • Pediatric poisoning rates are increasing.
  • Adult medication use is a contributing factor to household drug exposure.
  • Effective strategies include appropriate use of child-resistant packaging and drug take-back programs.

Conclusions:

  • Healthcare providers should promote safe medication storage and disposal.
  • Drug take-back programs are vital for reducing unused medications in homes.
  • Public health initiatives are needed to address preventable childhood injuries from poisoning.

Keywords:
pediatricpharmaceutical poisoningpoisoningprevention

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.6K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.4K

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
910
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
203
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
200